Search Results - aldons+lusis

5 Results Sort By:
y-AApeptide-based long-acting pan-coronavirus fusion inhibitor with dual targets in spike protein and oral bioavailability
­Advantages: S-20-1 demonstrates potent inhibitory action, this broad-spectrum activity suggests that S-20-1 could be effective against a wide range of coronaviruses, making it a valuable candidate for pandemic preparedness and management. The research provides insights into the mechanism of action of S-20-1, demonstrating its ability to bind...
Published: 9/25/2023   |   Inventor(s): Jianfeng Cai, Shibo JIANG, Lu LU, Songyi XUE, Xinling WANG, Lei WANG, Wei XU, Shuai XIA
Keywords(s): Drug Discovery, Immunology
Category(s): Technology Classifications > Medical > Biotechnology
2020-404 IDENTIFICATION OF NOVEL BIOMARKERS FOR NON-ALCOHOLIC FATTY LIVER DISEASE
SUMMARY: UCLA Researchers in the department of medicine have discovered distinct protein signatures in the blood of patients with non-alcoholic fatty liver disease (NAFLD) as well as NAFLD-related traits including steatosis, hepatocellular ballooning, and non-alcoholic steatohepatitis (NASH). These proteins were identified using the next-generation...
Published: 9/5/2023   |   Inventor(s): Adriana Huertas Vazquez, Aldons Lusis
Keywords(s):  
Category(s): Diagnostic Markers > Targets And Assays, Therapeutics > Metabolism And Endocrinology
2016-876 DEVELOPMENT OF A METHOD FOR ENDOCRINE NETWORK DISCOVERY UNCOVERS PEPTIDE THERAPEUTIC TARGETS
Development Of A Method For Endocrine Network Discovery Uncovers Peptide Therapeutic TargetsSUMMARYUCLA researchers in the Division of Cardiology at the Geffen School of Medicine have developed a bioinformatics methodology to identify and functionally annotate novel endocrine pathways.BACKGROUNDBeginning with the discovery of insulin, endocrine tissue...
Published: 8/2/2024   |   Inventor(s): Aldons Lusis, Marcus Seldin
Keywords(s): Life Science Research Tools, Software
Category(s): Life Science Research Tools, Software & Algorithms > Programs
2014-730 AGPAT5 as a Molecular Mediator of Insulin Resistance
AGPAT5 as a Molecular Mediator of Insulin ResistanceSUMMARYUCLA researchers in the Departments of Medicine and Cardiology have identified a novel gene and pathway in the regulation of insulin sensitivity and discovered an inhibitor of this gene useful for treating AGPAT5-related diseases.BACKGROUNDInsulin resistance (IR), a condition in which the body’s...
Published: 7/19/2023   |   Inventor(s): Aldons Lusis, Brian Parks, Richard Lee
Keywords(s): Cardiovascular, Diagnostic Markers & Platforms, Metabolic Diseases, Therapeutics & Vaccines
Category(s): Diagnostic Markers, Therapeutics, Therapeutics > Cardiovascular, Therapeutics > Metabolism And Endocrinology
Network-Coded Multiple Access
[Licensing negotiation in progress] [Invitation for Expression of Interest - Deadline: 16 June 2016] Systems and methods include a first wireless local area network (WLAN) system that jointly exploit physical-layer network coding (PNC) and multi-user decoding (MUD) to boost system throughput. This multiple access mode is referred to as Network-Coded...
Published: 1/29/2024   |   Inventor(s): Soung Chang Liew, Lu LU, Lizhao You
Keywords(s): Network Coding, Wireless Local Area Network
Category(s): Information and Communications Technology